ABIONYX Pharma

Company Description

---

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there is no effective or existing treatment, even the rarest ones

Thanks to its partners in research, medicine, its bioproduct suppliers and its shareholders, the company innovates on a daily basis to propose drugs for the treatment of renal and ophthalmological diseases, or new HDL vectors used for targeted drug delivery.

Headquarters

---

Bât. D2 33-43 Avenue Georges Pompidou, 31130 Balma – France

Shares outstanding

---

27,914,274

IPO

---

March 30, 2015

Stock exchange(s)

---

Euronext Paris